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Objectives: To evaluate the effect of a chewing exercise on pain intensity and pressure-pain threshold in patients with myofascial pain. Methods: Twenty-nine consecutive 
women diagnosed with myofascial pain (MFP) according to the Research Diagnostic 
Criteria comprised the experimental group and 15 healthy age-matched female were used 
as controls. Subjects were asked to chew a gum stick for 9 min and to stay at rest for 
another 9 min afterwards. Pain intensity was rated on a visual analog scale (VAS) every 
3 min. At 0, 9 and 18 min, the pressure-pain threshold (PPT) was measured bilaterally 
on the masseter and the anterior, medium, and posterior temporalis muscles. Results: 
Patients with myofascial pain reported increase (76%) and no change (24%) on the pain 
intensity measured with the VAS. A reduction of the PPT at all muscular sites after the 
	
	


	
		


following conclusions can be drawn: 1. there are at least two subtypes of patients with 
myofascial pain that respond differently to experimental chewing; 2. the chewing protocol 
had an adequate discriminative ability in distinguishing patients with myofascial pain from 
healthy controls.
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INTRODUCTION
Pain in the masticatory muscles is the 
most prevalent symptom associated with 
temporomandibular disorders (TMD), being present 
in 88.7% of the affected population6. Function 
impairment is also experienced by TMD patients, 
including reduced chewing ability. Kurita, et al.13 
(2001) found a positive correlation between chewing 
ability and TMJ pain and reduced mouth opening 
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found for noises and muscle tenderness.
Different types of muscle hyperactivity have 
been associated with muscle pain, among those 
bruxism, as well as extensive voluntary repeated 
maximum contractions, innate weakness in the 
strength of a muscle accentuated by repeated 
maximum contractions and continuous use of the 
muscle18. The overuse of the masticatory muscles 
has also been associated with changes in the blood 
supply, suggesting that ischemia may occur during 
contraction above a given threshold18.
Lobbezoo-Scholte, et al.14 (1993) studied the 
validity of six tests to discriminate patients from 
control subjects and found that passive opening 
measurement and palpation were the most useful 
for this purpose. Dao, Lund and Lavigne5 (1994) 
and Gavish, et al.8 (2002) concluded that pain 
can be either increased, decreased or unaltered 
when assessed the discriminative power of 
an experimental chewing test in patients with 
myofascial pain (MFP). The existence of two different 
pathologies or different pre-exercise pain levels 
could explain these different reaction5. Gavish, et 
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al.8 (2002) carried out a similar study, increasing 
the exercise time and measuring the pain using the 
Visual Analogue Scale (VAS) over 9 min at rest. 
They concluded that a strenuous chewing exercise 
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of MFP. In spite of that, the phenomenon of pain 
reduction in a small percentage of the patients with 
MFP should be further investigated.
Pressure-pain threshold (PPT) has been 
extensively used in diagnostic studies19,23 of 
myogenic TMDs as well as in therapeutic studies15, 
but little is known about the impact of chewing 
exercises on PPT measurements of symptomatic 
patients. Farella, et al.7 (2001) evaluated those 
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reduction after the test.
Investigators have used some exercises to 
induce muscle pain, such as tooth grinding2, 
experimental chewing5,8, electromyographically 
controlled clenching2,3, and maximal protrusion19. 
The literature has demonstrated that muscular 
hyperactivity exerts an important role as an 
etiological factor in this pain modality, since a 
symptomatic muscle pain relief has been observed 
concomitant to reduction in muscular activity6,17.
The purpose of this study was to test whether 
there are distinct pain responses to chewing 
exercise among patients with MFP with mild to 
moderate pain, and verify whether this protocol 
could be used to distinguish patients with MFP from 
control subjects.
MATERIAL AND METHODS
Subjects
The MFP group consisted of 29 consecutive 
Caucasian women (mean age 29.83±8.43 years, 
ranged from 18 to 49) selected among those 
seeking for treatment at the Orofacial Pain Clinic 
of the Bauru School of Dentistry, University of 
São Paulo, Brazil. Inclusion criteria followed the 
diagnostic of MFP (Group Ia), according to the 
Research Diagnostic Criteria (RDC/TMD)6. Patients 
with more than two absent teeth, history of facial 
or cervical injury, cervical pain or limited range of 
motion, active periodontal disease or caries, history 
of general neurological disturbances cervical and/
or masticatory active trigger points were excluded 
from the study. The diagnosis of TMJ disorders, 
according to RDC/TMD6 (diagnostic II) were also 
an exclusion criterion, although individuals with 
asymptomatic disc displacement joint (IIa, without 
pain) concomitant with Ia diagnostic (RDC/TMD6) 
were allowed to participate. The patients should not 
have taken any analgesic medication within  24 h 
prior to the experimental procedure. 
The control group was comprised by 15 
asymptomatic Caucasian women (means age 
25.47±1.23 years, ranged from 20 to 35) recruited 
at the regular dental clinics of the Bauru School 
of Dentistry. None of the subjects had any facial 
pain complaint or underwent TMD treatment 6 
months prior to the experiment. Except for pain, 
the inclusion criteria for the control group were the 
same to the used for the MFP group. All participants 
granted a written informed consent to participate 
in the study (126/2004).
Experimental Design
All participants filled out the RDC/TMD6 
questionnaire and were examined by one of the 
authors. The digital palpation was carried out 
with a pressure of 1.0 kgf to the extraoral sites 
and approximately 0.5 kgf to the intraoral and 
articular sites, as recommended by the RDC/TMD6. 
This pressure was previously calibrated using 
an algometer (Dinamometer model DDK, Kratos 
Equipamentos, Cotia, SP, Brazil ).
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bias9-11,20,22, palpation of the “lateral pterygoid 
area”, though part of the screening evaluation 
(RDC/TMD6), was replaced by palpation of the deep 
portion of masseter, in order to maintain the 20 
sites proposed in RDC protocol, as documented in 
previous studies1,21,23.
Fol lowing the cl inical examination, an 
experimental chewing exercise was performed, 
	+		8 (2002). The 
test was performed with the same interval time, 
though with a different chewing material.
During the sessions of the chewing test, the 
subjects were seated comfortably in a dental chair, 
in an upright position and with their heads leaning 
back on the headrest. Before the chewing test (P0), 
the participants were asked to indicate their pain 
intensity on a Visual Analog Scale (VAS), which 
ranged from 0 mm (“no pain”) to 100 mm (“the 
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on a separate piece of paper in order to avoid bias 
of previous VAS records.
With the aid of an algometer, the PPT of the 
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anterior (AT), medium (MT) and posterior temporalis 
(PT) muscle was also established bilaterally before 
the test (PPT0). With a rate of application of about 
0.5 kg/cm2/s, the pressure was applied until it 
became painful. At this point, the participant was 
instructed to push a hand-held button attached 
to the algometer, so the amount of pressure was 
automatically recorded by the device.
After recording the baseline measurements 
(VAS and PPT), the subjects were instructed to 
start chewing. They were requested to chew on a 
stick of chewing gum (Trident®, Cadbury, Bauru, 
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SP, Brazil) for 9 min at the preferred side. After 
that, individuals were instructed to hold their jaws 
at a rest position (lips together and teeth apart) 
for additional 9 min, completing the total period 
test of 18 min.
VAS was recorded again after 3, 6, and 9 min 
(P3, P6, and P9, respectively) after the beginning 
of the experiment, and during the rest period at 12, 
15 and 18 min (P12, P15, and P18, respectively), 
while PPT measurements were taken at times 9 
(PPT9) and 18 (PPT18).
The Kolmogorov-Smirnov test was used to verify 
homogeneity in all groups (P<0.05). The student’s 
t test (parametric data) and Mann-Whitney test 
(non-parametric data, P<0.05) were used to verify 
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and MFP groups regarding VAS and PPT. ANOVA for 
repeated measures and Tukey’s test (parametric 
data) and Friedman’s test followed by the Student-
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data) were used to verify intragroup differences in 
different moments of PPT records. The statistical 
analysis was performed using the SigmaStat 2.0 
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CA, USA).
RESULTS
Patients with MFP presented the following values 
of VAS (present pain: 47.79±22.27 mm; mean 
pain in the last six months: 50.34±2.03 mm, and 
maximal pain in the last six months: 67.93±19.34 
mm). They had a mean active mouth opening of 
45.90±10.95 mm and a mean number of sensitive 
palpation sites of 8.37±4.73 mm. On the other 
hand, control group had no pain on the VAS; 
45.07±6.55 mm of mean active mouth opening; 
and a mean number of sensitive palpation sites of 
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the differences in VAS pain intensity and in mean 
number of sensitive palpation sites (p<0.001). 
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opening (p=0.334).
Chewing test
At P9, patients with MFP reported a mean 
pain increase of 18.79 mm, while controls had 
an increase of 3.33 mm in VAS records. None of 
the patients with MFP reported pain reduction, 7 
(24%) reported no change in pain (MFP NCP), and 
22 (76%) reported an increase (MFP IncP). Within 
the MFP IncP patients, the mean increase of pain at 
P9 was 23.59 mm. However, at P12, two additional 
patients experienced an increase in pain, elevating 
the percentage of this subgroup to 82.76% (24 
subjects) and reducing the percentage of patients 
who had no change in pain (MFP NCP) to 17.24% (5 
subjects). For the control group, 13 (87%) patients 
had no change in pain and only 2 subjects (13%) 
experienced pain increase at P9. Data concerning 
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in both groups at the different measurement points 
are presented in Figure 1.
When applied a Friedman repeated measures 
ANOVA on ranks on VAS scores of both groups, no 
statistical difference was found in the control group 
along the whole experiment (exercise and rest) 
(Figure 1). Conversely, the MFP group showed a 
clear increase on pain intensity from P0 up to P9. 
From this point, a slight decrease in the intensity 
levels was revealed, but not enough to recover to 
pre-exercise levels (Figure 1).
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intensity between these subgroups was found after 
chewing (p=0.002).
Analysis of covariance of pain levels during 
Figure 1- Pain intensity during the chewing test of patients with myofascial pain (MFP) and control subjects. * the same 
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the chewing experiments yielded the following: a 
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P=0.002) and for time (p<0.001), but not for 
activity (chewing or rest). Also a significant 
interaction between group, activity and time 
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effect of the chewing activity on the pain level 
in both groups over time, but do not indicate a 
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group, the pain increased 18.79 mm at P9 and 
recovered to levels above (13.00 mm) the pre-
exercise levels.
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MFP than in controls at all recording sites and at 
all the times (PPT0 to PPT18). Figure 2 shows PPT 
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and 18, respectively) of each muscular site of MFP 
and control group. Data from right and left sides 
were pooled because PPTs obtained bilaterally in 
the jaws have been shown to be correlated15. In the 
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PPT9 were observed only in anterior and posterior 
temporalis. For the MFP group, PPT9 values were 
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period (PPT18), however, the PPT values remained 
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(PPT0) (Figure 2).
Among the patients with MFP, 18 (62.07%) 
started the exercise with VAS pain between 0 and 
5 mm (MFP P0=0). In order to evaluate the weight 
  		 
  
	  	

between MFP P0=0 and those who started with VAS 
higher than that were made:
Intergroup evaluation: The MFP P0=0 patients 
showed PPT0 values significantly higher than 
those who started exercise with EAV greater than 
0 (MFP>0); and similar to pre-exercise PPTs of 
control group. After chewing, MFP P=0 patients 
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group for all recording sites.
Intragroup evaluation: Regarding the masseter 
muscle, MFP P0=0 showed a pattern similar to 
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At PPT18, the values remained low in comparison 
to pre-exercise levels. For the AT, MT and PT, MFP 
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at PPT 18 the values had a trend to recover to 
PPT0 values, and ended up at intermediate levels 
between PPT0 and PPT9. Regarding the MFP P>0 
subgroup, the PT presented a similar pattern to the 
M, with PPT18 remaining lower than PPT0. Both 
the AT and MT showed a tendency of the PPT18 to 
recover to the PPT0 level, with intermediate levels 
between PPT0 and PPT9.
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despite the elevated PPT0 (similar to controls), 
presented a particular reaction to the exercise, with 
a more accentuated decrease in PPT than controls 
(PPT9 MFP P0=0<PPT control). Even after rest, MFP 
P0=0 continued to have reduced PPT in relation to 
the control group.
Seven patients with MFP did not present any 
change in VAS pain (MFP NCP) at P9. Out of those, 
six presented P0=0 and one had P0= 59 mm (Figure 
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between patients with MFP who had no change in 
pain versus who had increase in pain.
Intergroup evaluation
PPT 0: The PPT0 of MFP NCP patients were 
similar to MFP IncP (exception made for the 
posterior temporalis); and lower than the control 
group for all muscle sites.
PPT9: At all muscles sites, but the anterior 
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the control group (Figure 3). It means that PPT9 
of MFP NCP were in between the control group and 
MFP IncP.
PPT18: After rest (PPT 18), MPF NCP showed PPT 
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than the control group at all muscle sites but the 
PT (Figure 4).
Intragroup evaluation
With the exception made for the MT, which PPT9 
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both subgroups presented similar PPTs evolution 
pattern along the whole experiment, i.e., PPT9 

	
	
''$	
''!
	

lower than PPT0 and similar to PPT9 (Figure 4). 
That means that, regardless of VAS evolution, the 
MFP group experienced a decrease of PPT after 
the exercise, and 9 min of rest are not enough to 
recover it to pre-exercise levels.
The discriminative ability of the test to distinct 
patients from controls was demonstrated by a 

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likelihood ratio (LR+) of 5.69 (CI95: 1.992–31.012), 
and a negative likelihood ratio (LR-) of 0.28 (CI95: 
0.128–0.515). A pre-test probability of 66% (0.66), 
post-test probability to LR+ of 0.92 (92%) and to 
LR- of 0.35 (35%) were also found, while the odds 
ratio (OR) was 20.37. It means that the risk of a 
person who report increase in pain to have MFP 
is 0.92 (92%), while the risk of a person who do 
not change in pain with this protocol to have MFP 
is 0.35 (35%). Therefore, the relative risk is 2.62. 
The Chi-square was 15.590 (p=0.000078).
DISCUSSION
Despite the small sample size, the experimental 
and control groups clearly demonstrated different 
responses after the experimental chewing. The 
increase in pain intensity in the MFP group along 
the chewing exercise was significantly higher 
when compared to the healthy controls. This fact 
highlights ultimate differences in pain behavior upon 
function between healthy subjects and patients 
with MFP. 
Figure 3- Pain during chewing test of patients with myofascial pain who reported a pain increase (MFP IncP), x no change 
in pain (MFP NCP) an control subjects
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Figure 4- Pressure-pain threshold (PPT) during chewing test [patients with myofascial pain who reported a pain increase 
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temporalis; PT= posterior temporalis
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Gavish, et al.8 (2002) and Dao, Lund and 
Lavigne5 (1994) showed mean pain increases of 
28.3 e 32 mm, respectively (values above the 
smallest detectable difference12). In the present 
study, this pattern was of 23.59 mm. Differences in 
the pre-test pain VAS may explain that difference. 
While the present study obtained mean initial values 
of VAS of 12.03±18.27 mm (18 patients with pre-
exercise VAS=0), Dao, Lund and Lavigne5 (1994) 
had 35.2±2.7 mm (all patients with EAV>0) and 
Gavish, et al.8 (2002) 25.06±26.42 mm.
The frequency of patients which experienced 
variations in pain intensity during functional 
exercise was pointed out by earlier studies, as 
followed: increase in pain (48.3%5 and 84%8); no 
change in pain (20%5 and 10%8); and reduction in 
pain (31.7%5 e 6%8). In the present study, 76% 
of the sample experienced pain increase, and 
24% reported no change. None of the individuals 
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are in accordance to Gavish, et al8 (2002) and 
could be explained due to similar inclusion criteria, 
which excluded patients with cervical trigger points 
and arthralgia. Dao, Lund and Lavigne5 (1994) 
hypothesized that the reaction to exercise may be 
related to the pre-exercise pain level, since the 
patients who presented a decrease in pain had a level 
	

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mm) than those who had an increase in pain 
(27.5±3.1 mm). Again, the mean low pre-
exercise pain level observed in this study could 
be responsible for the absence of this occurrence. 
Undoubtedly, this feature limits the comparison with 
other studies. A more comprehensive sample with 
patient subgroups for pain intensity (low, mild and 
=
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of Dao, Lund and Lavigne5 (1994). Also, to avoid 
confounding factors, the present study ruled out 
individuals with any sign of referred pain due to 
trigger points, as well as those that had taken 
any analgesic medication within 24 h prior to the 
experiment. Thus, a more homogenous sample of 
patients with MFP with mild (n=18) and moderate 
(n=11) pain levels was composed.
Among the control subjects, only 2 showed 
increased VAS after the exercise, while the 
remaining 13 reported no change in pain intensity. 
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 
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Farella, et al.7 (2001), who reported no change on 
VAS in healthy subjects after 40 min of chewing 
on a soft gum. 
Silva, et al.19 (2005) demonstrated cut-off 
values of PPT to each of muscular sites evaluated 
in the present study. They found 1.5, 2.47, 2.75, 
and 2.77 kgf/cm2 to the superficial masseter 
(belly), and the anterior, middle, and posterior 
	$
In the present study all pre-exercise mean PPTs of 
patients with MFP were below those cut-off values 
(1.40, 1.60, 1.85, and 1.94 kgf/cm2 respectively). 
However, mean pre-exercise PPTs of control 
subjects to anterior and middle temporalis stayed 
just below them (2.13 and 2.32 kgf, respectively), 

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At chewing completion (PPT9), all PPTs of patients 
with MFP were lower than baseline (PPT0), whereas 
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PPT only for the anterior and posterior temporalis, 
with subsequent recovery to similar PPT0 levels at 
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of Christensen, et al.4 (1996) and Farella, et al.7 
(2001) who gave further evidence that the human 
jaw muscles in healthy subjects recover quickly 
after prolonged gum chewing, demonstrating that 
the amount of masticatory loading did not affect 
muscle tenderness in healthy subjects.
Based on PPT evolution of the control group, MFP 
NCP and MFP IncP, it could be assumed that the 
pain/PPT behavior during the exercise in patients 
with MFP seems to be associated to the pre-exercise 
pain (VAS) and PPT levels. Nevertheless, it is not 
	
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Dao, Lund and Lavigne5 (1994) due to differences 
in pre-exercise pain levels.
After chewing (P9), MFP NCP patients, showed a 
more similar pattern to MFP IncP than to the control 
group. Despite of this similarity, MFP NCP patients 
showed PPT9 values statistically greater than MFP 
IncP. This fact may be explained by the differences 
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(p=0.012 for PT, 0.057 for MM; and 0.051 for AT). 
The differences in PPT9 values between MFP NCP 
and IncP patients could be also due to pre-exercise 
PPT values. Patients with mild VAS pain tend to 
present a mild VAS pain reaction on to exercise and 
those with moderate VAS pain trend do present, 
also, a moderate reaction to exercise. Similarly, 
the PPT0 values seem to be the main factor to the 
tenderness exacerbation during function. 
Pain stimulation or exacerbation in patients 
with MFP due to chewing is well demonstrated 
as one of the most important characteristics of 
musculoskeletal pain. McMillan and Blasberbg15 
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	
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with MFP. Farella, et al.7 (2001) described that the 
exercise-induced pain and fatigue has been related 
to ischemia and to accumulation of metabolic waste 
products. Indeed, it has been shown that during 
	   	   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may be hampered, probably due to an increased 
intramuscular pressure and nipping of the vessels 
entering the muscle. However, Nielsen, et al.18 
(1990) demonstrated that subjects with muscle 
pain in craniomandibular muscles, regardless the 
location of the pain and the muscle involved, recruit 
Effect of experimental chewing on masticatory muscle pain onset
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the anterior temporalis and masseter muscles less 
often and with lower activity.
The sensitization of muscle nociceptors is 
probably the peripheral mechanism underlying 
local tenderness and the pain upon function of a 
pathologically altered muscle, related to the release 
of endogenous substances, such as prostaglandin 
and bradykinin. Central mechanisms also contribute 
for this event in chronic pain patients, as very well 
documented16,17.
Despite the presence of some patients with 
MFP who did not change in pain to exercise, this 
protocol presented an OR value greater than the 
majority of combined orthopedic tests in a previous 
study14. Those authors studied the discriminative 
ability of six orthopedic tests and combinations to 
distinguish different subtypes of TMD (myogenous 
and arthrogenous). For this reason, it is not possible 
make any direct comparison with our OR values.
The sensitivity of this test was higher than 
the minimal acceptable level (0.75) reported by 
Widmer, Lund and Feine24 (1990). However, the 
specificity remained just below the minimum 
acceptable values of 0.9024  

  
present study (LR and OR) indicate an adequate 
discriminative ability of this protocol to distinguish 
patients with MFP from healthy controls. However 
further studies with a more representative sample 
of patients with MFP with low, moderate and severe 
intensities of pain are necessary.
CONCLUSIONS

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evidence that: 1) There are at least two subtypes of 
patients with MFP who can be expected to respond 
differently to experimental chewing, either with 
an increase in pain or not; 2) Probably because of 
different reactions to exercise within the MFP group, 
this protocol showed an adequate discriminative 
ability; and 3) The pre-exercise pain/PPT levels 
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''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to exercise in patients with MFP with mild and 
moderate pain.
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